Skip to main content
European Radiology Experimental

Table 3 Treatment details and outcomes of post-treatment imaging for the 15 patient participants with histologically confirmed squamous cell carcinoma

From: Oxygen-enhanced MRI assessment of tumour hypoxia in head and neck cancer is feasible and well tolerated in the clinical setting

  1. Radiotherapy dose presented is delivered to the region containing the primary tumour. Post-treatment imaging was completed for 10 patients with one of them having an MRI scan rather than an FDG-PET scan due to the clinical circumstances. Highlighted rows indicate those patients with residual disease in the primary tumour on post-treatment imaging
  2. CRT Concurrent chemoradiotherapy, FDG-PET18F-fluorodeoxyglucose positron emission tomography, RT Radiotherapy, SACT Systemic anticancer therapy
Back to article page